How is tirzepatide different from a classic GLP-1?

Tirzepatide is a dual receptor agonist (GLP-1 and GIP) which, in trials, shows larger average weight loss than mono-agonist GLP-1s in adults with obesity.

What does the doctor review before prescribing tirzepatide?

History of pancreatitis, gallbladder issues, family history of medullary thyroid cancer, pregnancy or plans to conceive, and current medication. Recent labs are also reviewed if provided.

What follow-up does Hi-Doctor offer during treatment?

Quarterly medical review through the private in-app chat, dose adjustments if side effects arise, and a new electronic prescription valid in any EU pharmacy when applicable.

Is Mounjaro the same thing as tirzepatide?

Yes. Tirzepatide is the active ingredient, and Mounjaro is the brand name it is sold under in the European Union. In the United States the same molecule is also sold as Zepbound for weight management, but Zepbound is not authorised in the EU, so an EU prescription for tirzepatide will be written for Mounjaro. The European Medicines Agency authorised Mounjaro on 15 September 2022, and its licence now covers both type 2 diabetes and weight management in adults who meet the BMI criteria.

What happens if I stop taking tirzepatide?

Weight tends to come back. In SURMOUNT-4, adults who had already lost a mean of 20.9% over a 36-week lead-in were randomly assigned either to keep taking tirzepatide or to switch to placebo. Between week 36 and week 88 the continued group changed by a further -5.5%, while the placebo group regained 14.0%. At week 88, 89.5% of the continued group had kept at least 80% of the weight lost during the lead-in, compared with 16.6% of the placebo group. Stopping is a decision to make with your prescriber.

Does everyone have to go up to the 15 mg dose?

No. The product information lists 5 mg, 10 mg and 15 mg as the recommended maintenance doses, so 5 mg and 10 mg are licensed end points in their own right and not only steps on the way up. In SURMOUNT-1 the 5 mg group had a mean body-weight change of -15.0% at 72 weeks, the 10 mg group -19.5% and the 15 mg group -20.9%. Gastrointestinal side effects were also more frequent at higher doses. Your prescriber decides where to stop, based on how you respond and how well you tolerate each step.

Can I get a consultation for Mounjaro from Riga?

Yes. Hi-Doctor runs 100 % online across the EU, so if you live in Riga you can fill in the questionnaire and receive the medical review without travelling. The electronic prescription issued by the licensed doctor is valid in any EU pharmacy under Directive 2011/24/EU; outside Spain, the pharmacist dispenses the locally marketed equivalent of the same active ingredient.

Who is a candidate for a medical weight-management programme?

Adults with BMI ≥ 30, or ≥ 27 with comorbidities (hypertension, type-2 diabetes, dyslipidaemia). The doctor reviews your history, current medication and goals before proposing any treatment. It is not a cosmetic programme.

What is the private electronic prescription and why is it valid across the EU?

The private electronic prescription (Receta Médica Privada Electrónica) is issued by a licensed doctor in Spain. It is a PDF carrying every field required by EU Directive 2011/24/EU (patient, prescriber with country of registration, active ingredient, dose), which makes it legally recognised across all 27 EU member states. In Spanish pharmacies it is dispensed from the QR; outside Spain, the pharmacist dispenses the locally marketed equivalent of the same active ingredient.

How does Hi-Doctor work step by step?

1) Fill in an online medical questionnaire in about 4 minutes. 2) The plan is €25/month for weight loss or €15/month (billed €45 every 90 days) for hair growth; sexual health is €35 per consultation and a skin consultation is €40. 3) An EU-licensed doctor reviews your case and, if appropriate, issues an electronic prescription. 4) Collect it at any EU pharmacy. If the review is not approved, the applicable fee is refunded in full.

How much does it cost and what does the price include?

The plan is €25/month for weight loss or €15/month (billed €45 every 90 days) for hair growth; a one-off sexual-health consultation is €35 and a skin consultation — acne, rosacea, melasma, ageing skin — is €40. Each includes a licensed doctor's review and an electronic prescription if approved. If the review is not approved, the applicable fee is refunded in full. Medication is paid for separately at the pharmacy at the price it sets.

Mounjaro · RigaPrescription only

Online medical consultation for Mounjaro in Riga.

An EU-licensed doctor reviews your case and, if eligible, issues an electronic prescription valid in any pharmacy in Latvia. Consultation €25/month, refunded if the doctor decides it is not safe to prescribe.

Mounjaro pack shot — a prescription medicine an EU-licensed doctor can prescribe online after a Hi-Doctor consultation in Riga.

Once-weekly pen
Dual GIP/GLP-1 receptor action
Doctor-supervised, step-wise escalation

Start consultationStart consultation · €25/month

Full refund if a review is not approved · Medication, if prescribed, is dispensed and paid for separately at a pharmacy.

IN PLAIN TERMS

What Mounjaro is, and how to get treatment

Mounjaro (tirzepatide) is a once-weekly injection for weight management. It copies two gut hormones — GIP and GLP-1 — which together reduce appetite, slow how quickly your stomach empties, and help steady your blood sugar. It is authorised across the EU and is prescribed by licensed doctors when clinically appropriate.

Mounjaro has been authorised for use in the EU since 15 September 2022, so a licensed doctor can prescribe it when it is clinically appropriate for you.

Learn more about peptides at Peptidepedia.

Can I get it?

Yes, if a doctor decides it is right for you. Mounjaro is authorised in the EU and can be prescribed after a medical review.

What can I take instead?

Our doctors review every Weight loss option and recommend what fits your history and goals.

See all Weight loss options

What do the studies show?

Every trial behind Mounjaro is listed below with its registry number, how many people took part, and whether the results are peer-reviewed or a company announcement.

Jump to the studies

Local consultation facts

Can I get Mounjaro in Riga?

Yes. People in Riga, Latvia, can request an online doctor consultation about Mounjaro with Hi-Doctor. A licensed EU doctor reviews the case and issues a prescription only when clinically appropriate. If approved, the EU prescription arrives as a PDF for a pharmacist in Latvia, who dispenses the locally marketed equivalent containing Tirzepatide.

Availability

Mounjaro is available to residents of Latvia through the online consultation. A prescription follows only if the doctor approves it.

Country: Latvia
Language of service: Spanish and English
Prescription turnaround: In less than 4 hours on average, only if the doctor approves
Honoured locally: PDF honoured locally for an equivalent containing Tirzepatide

How the EU prescription works where you are: In Latvia, show the approved prescription PDF to a pharmacist. They honour it under EU cross-border rules and dispense the locally marketed equivalent containing Tirzepatide.

VERIFIED EVIDENCE

Mounjaro: evidence and regulatory guide.

Mounjaro contains tirzepatide, an EU-authorised prescription medicine. The data below separate its regulatory status from the pivotal trial result.

WHAT IT IS

How it works

Tirzepatide is a once-weekly dual agonist that activates GIP and GLP-1 receptors. It has no glucagon component.

GIP
GLP-1

DEVELOPMENT STAGE

EU-authorised medicine

The EMA marketing authorisation has been valid across the EU since 15 September 2022 under EMEA/H/C/005620.

Trial register1 registered trials

Every NCT identifier links to its ClinicalTrials.gov record. A readout is not the same as peer-reviewed publication.

Registered trials for Mounjaro
TRIAL / NCT	POPULATION	PARTICIPANTS	STATUS	READOUT / COMPLETION
SURMOUNT-1NCT04184622	Obesity or overweight without diabetes	2,539	Read out	2022

What the studies reported

Results are grouped by source and evidence grade so journal data and manufacturer announcements cannot be confused.

Peer-reviewed

SURMOUNT-1, NEJM 2022;387(3):205-216 · DOI: 10.1056/NEJMoa2206038

SURMOUNT-1, NEJM 2022;387(3):205-216 · DOI: 10.1056/NEJMoa2206038
DOSE OR GROUP	MEAN WEIGHT CHANGE	WEEKS
Placebo	−3.1%	72
5 mg	−15.0%	72
10 mg	−19.5%	72
15 mg	−20.9%	72

Peer-reviewed SURMOUNT-1, N=2,539, 72 weeks. This was a separate trial with its own population, sites and placebo response.

Sources

Last reviewed 2026-07-27

FormPre-filled injection pen

FrequencyOnce a week

ResultsGradual, over months

StatusPrescription only

About

What is Mounjaro?

Active ingredient: Tirzepatide · Dosages: 2.5 – 15 mg / week

Tirzepatide is a dual receptor agonist — it acts on the GLP-1 and GIP gut-hormone receptors at the same time. In clinical trials this translates into larger average weight loss than mono-agonist GLP-1s in adults with obesity.

It's a chronic treatment for as long as it's beneficial and safe: the doctor reviews your response every 3 months and decides with you whether to continue, adjust or stop. Discontinuation is gradual and paired with a maintenance plan.

How it works in the body

By activating two receptors at once, tirzepatide reinforces satiety signals, slows stomach emptying and helps regulate the insulin response — so you tend to eat less without counting every calorie.

How it helps

Three ways it supports weight loss.

Dual action

Works on two gut-hormone receptors (GLP-1 + GIP), not just one.

Reinforces satiety

Hunger eases and fullness lasts longer after smaller meals.

Reviewed quarterly

Your doctor reassesses response and tolerance every 3 months before renewing.

What to expect

A step-wise, supervised escalation.

The dose is escalated step-wise (2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg) every 4 weeks while the body adapts. Your doctor sets your exact schedule.

Weeks 1–4 · 2.5 mg starting dose
From week 5 · Step up every 4 weeks as tolerated
Month 4+ · Personalised maintenance dose
Ongoing · Quarterly medical reviews

Typical escalation

Weeks 1–42.5 mg / week
Step-ups (every 4 weeks)5 → 7.5 → 10 → 12.5 mg
Maximum dose15 mg / week

Your schedule is personal

These are typical steps only. Your doctor adjusts the plan to how you respond and tolerate it — and you can message them at any point.

Safety first

Safety, in full.

Mounjaro is an effective medicine — and like any medicine it carries risks. Your doctor screens for all of this before prescribing. Here's the honest picture, not just reassurance.

Adults with obesity (BMI ≥30) or with overweight (BMI ≥27) plus at least one weight-related condition.

Once-weekly self-injection in the thigh, abdomen or upper arm.
Dose is escalated step-wise (2.5 mg → 5 → 7.5 → 10 → 12.5 → 15 mg) every 4 weeks while the body adapts.
Combined with diet and physical activity — tirzepatide complements, not replaces, lifestyle change.

Who should not take it

Personal or family history of medullary thyroid carcinoma or MEN 2.
Pregnancy, planned pregnancy in the next 2 months, or breastfeeding.
History of pancreatitis.
Type 1 diabetes or diabetic ketoacidosis.
Severe gastroparesis.

When to seek urgent care

For severe, sudden or unexpected symptoms, call your local emergency number or go to the nearest emergency department. Then let your doctor know through your account chat.

Read the full Mounjaro safety summary

PRICING

You only pay if treatment is approved.

€25/month for weight loss or €15/month (billed €45 every 90 days) for hair growth. One-off consultations are €35 for sexual health and €40 for dermatology.